

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
We will give women everywhere control of their sexual and reproductive health.
2 employees at Evofem Biosciences have reviewed Evofem Biosciences across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.









Lack of leadership. Very inexperienced.

Tell Evofem Biosciences you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give Evofem Biosciences the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Send them an invite to rate the company culture.